AngiopunctureNCT07176910
Doppler Ultrasound-Guided Angiopuncture for Dysmenorrhea Pain: A Clinical Trial
A study testing conduct angiopuncture on perforator points in people with Angiopuncture and Dysmenorrhea, run by City University of Hong Kong at 1 site in China.
Trial summary
the study is to evaluated dopplar guided angiopuncture efficacy and safety in patients with dysmenorrhea Read more about this study
- Who is it for?
- Ages 18 to 25 years, women only
- Conditions the study is for
- Angiopuncture, Dysmenorrhea, Dopplar Ultrasound
- What is being tested?
- conduct angiopuncture on perforator points
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteChina
- Study dates
- 1 Sep 2024to 1 Nov 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Primary dysmenorrhea diagnosis (≥6 months of menstrual pain scoring ≥2 on numerical rating scale) Regular menstrual cycles (28-32 days), menstrual period lasts 4 to 7 days No pelvic pathology on transvaginal ultrasound.
Who cannot join
- coagulopathy (INR >1.5) recent analgesic use (48-hour washout) secondary dysmenorrhea confirmed by laparoscopy.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
The Third Affiliated Hospital of Changchun University of Chinese Medicine
Changchun
Rong HAN, phd student, +852 61448549 ext. +852, ronghan5-c@my.cityu.edu.hk
About this study
the study is to evaluated dopplar guided angiopuncture efficacy and safety in patients with dysmenorrhea
Read the detailed description
to conduct angiopuncture, with dopplar located perforator points and also evaluate the spectrum before and after angiopuncture therapy.
- Conditions
- Angiopuncture, Dysmenorrhea, Dopplar Ultrasound
- Being tested
- conduct angiopuncture on perforator points
- Keywords
- Dysmenorrhea, angiopuncture, dopplar, ultrasound
- Medical subject headings
- Dysmenorrhea
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
conduct angiopuncture on perforator pointsOther
conducted angiopuncutre on patients of intervention group, and compare those patients pain scores before and after angiopuncture therapy.
| Study group | Role | What they receive |
|---|---|---|
| angiopuncture treated group | Experimental | conduct angiopuncture therapy Receives: Other: conduct angiopuncture on perforator points |
What is being measured
The primary outcome is the main question the study is designed to answer.
visual analog scale
to measure pain score before and after angiopuncture
Measured: pre-treatment, immediate post-treatment, check up 1, check up 2, check up 3 (3 check ups lasts for 3 months post therapy, with each for 1 month)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2025
- Study start1 Sep 2024
- Primary completion1 Oct 2025 (estimated)
- Study completion1 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AngiopunctureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- unmarried nulliparous women (aged 18-25 years old) with dysmenorrhea diagnosis
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- City University of Hong Kong
- Sponsor type
- University, hospital or other
- Collaborators
- The Third Affiliated Hospital of Changchun University of Chinese Medicine
- Responsible party
- Principal investigator, Rong Han, City University of Hong Kong
- Investigators
- Jinlian HU, PhD, Principal investigator, City University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07176910
- Sponsor's protocol ID
- 111
- Other IDs
- 9239056
- Status last verified
- Sep 2025
- First submitted
- 7 Sep 2025
- Last updated
- 16 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: we have not published the paper yet
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Doppler Ultrasound-Guided Angiopuncture for Dysmenorrhea Pain: A Clinical Trial
- ClinicalTrials.gov ID
- NCT07176910
- Acronym / sponsor ID
- 111
- Conditions
- Angiopuncture, Dysmenorrhea, Dopplar Ultrasound
- Keywords
- Dysmenorrhea, angiopuncture, dopplar, ultrasound
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- City University of Hong KongUniversity, hospital or other
- Collaborators
- The Third Affiliated Hospital of Changchun University of Chinese Medicine
- Study start
- 1 Sep 2024 (actual)
- Primary completion
- 1 Oct 2025 (estimated)
- Study completion
- 1 Nov 2025 (estimated)
- First posted
- 16 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
the study is to evaluated dopplar guided angiopuncture efficacy and safety in patients with dysmenorrhea
Detailed description
to conduct angiopuncture, with dopplar located perforator points and also evaluate the spectrum before and after angiopuncture therapy.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- unmarried nulliparous women (aged 18-25 years old) with dysmenorrhea diagnosis
| Arm | Type | Receives |
|---|---|---|
| angiopuncture treated group | Experimental | Other: conduct angiopuncture on perforator pointsconduct angiopuncture therapy |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Primary dysmenorrhea diagnosis (≥6 months of menstrual pain scoring ≥2 on numerical rating scale) Regular menstrual cycles (28-32 days), menstrual period lasts 4 to 7 days No pelvic pathology on transvaginal ultrasound.
Key exclusion criteria (1 listed)
- coagulopathy (INR >1.5) recent analgesic use (48-hour washout) secondary dysmenorrhea confirmed by laparoscopy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| conduct angiopuncture on perforator pointsconducted angiopuncutre on patients of intervention group, and compare those patients pain scores before and after angiopuncture therapy. | Other | angiopuncture treated group |
Primary outcome
visual analog scale
Time frame: pre-treatment, immediate post-treatment, check up 1, check up 2, check up 3 (3 check ups lasts for 3 months post therapy, with each for 1 month)
to measure pain score before and after angiopuncture
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2025.
- Individual participant dataSharing planned: No. we have not published the paper yet
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jinlian HU, PhD principal investigator
City University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing conduct angiopuncture on perforator points in people with Angiopuncture and Dysmenorrhea, run by City University of Hong Kong at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rong HAN, PhD student (+852 61448549 ext. +852, ronghan5-c@my.cityu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
visual analog scale (time frame: pre-treatment, immediate post-treatment, check up 1, check up 2, check up 3 (3 check ups lasts for 3 months post therapy, with each for 1 month)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2025.